JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate.
about
Activation of nuclear factor-kappaB and not activator protein-1 in cellular response to nickel compounds.A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivationCannabinoid-receptor-independent cell signalling by N-acylethanolaminesCadmium induces carcinogenesis in BEAS-2B cells through ROS-dependent activation of PI3K/AKT/GSK-3β/β-catenin signalingCyclin D1 induction by benzo[a]pyrene-7,8-diol-9,10-epoxide via the phosphatidylinositol 3-kinase/Akt/MAPK- and p70s6k-dependent pathway promotes cell transformation and tumorigenesisMAPK phosphatase DUSP16/MKP-7, a candidate tumor suppressor for chromosome region 12p12-13, reduces BCR-ABL-induced transformation.A new tumour suppression mechanism by p27Kip1: EGFR down-regulation mediated by JNK/c-Jun pathway inhibition.Mitogen-activated protein kinase activation in UV-induced signal transduction.Activation of JNK by TPA promotes apoptosis via PKC pathway in gastric cancer cellsOmega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells.PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cellsPI-3K/Akt pathway-dependent cyclin D1 expression is responsible for arsenite-induced human keratinocyte transformation.A cross-talk between NFAT and NF-κB pathways is crucial for nickel-induced COX-2 expression in Beas-2B cellsc-Jun/AP-1 pathway-mediated cyclin D1 expression participates in low dose arsenite-induced transformation in mouse epidermal JB6 Cl41 cellsEffect of ionizing radiation on the differentiation of ROS 17/2.8 osteoblasts through free radicals.Extracellular signal-regulated kinases 1/2 and Akt contribute to triclosan-stimulated proliferation of JB6 Cl 41-5a cells.The tumor suppressor p16(INK4a) prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity.Differential requirement of EGF receptor and its tyrosine kinase for AP-1 transactivation induced by EGF and TPA.AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.Involvement of c-jun NH(2)-terminal kinases in resveratrol-induced activation of p53 and apoptosis.Role of MAP kinases in UVB-induced phosphorylation of p53 at serine 20.Mitogen- and stress-activated protein kinase 1 mediates activation of Akt by ultraviolet B irradiation.Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability.Flavanones structure-related inhibition on TPA-induced tumor promotion through suppression of extracellular signal-regulated protein kinases: involvement of prostaglandin E2 in anti-promotive process.Activation of JNK1, RSK2, and MSK1 is involved in serine 112 phosphorylation of Bad by ultraviolet B radiation.A critical role of PI-3K/Akt/JNKs pathway in benzo[a]pyrene diol-epoxide (B[a]PDE)-induced AP-1 transactivation in mouse epidermal Cl41 cells.[6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin.Harvesting cells under anchorage-independent cell transformation conditions for biochemical analyses.Ten ERK-related Proteins in Three Distinct Classes Associate with AP-1 Proteins and/or AP-1 DNA
P2860
Q24812598-7566D0BD-01A6-45A2-A18E-92143F39D01EQ28213902-84D6F339-B62B-4F98-84FA-AE7FC22ECD09Q28363293-4FDD3E24-FADB-4AEE-B4AA-589E64003763Q28389261-44649C46-96AB-44D5-A465-042726B175E1Q28749707-5C54D5EB-569E-43B5-8F59-4ED85F6AC135Q34273369-3B030479-A68E-4FCE-AFA0-22F29626DE96Q34406424-918219C1-7FC5-4E26-A011-5A2CF2A103F9Q35055502-F1FCF2E2-FBEA-4AC4-8465-0F4A41909464Q36308361-1E19C082-292C-4B86-83D1-6500F075833CQ36313374-C79FB8E7-7C23-41BB-8726-D9AD87E816C6Q36321986-9705C471-C392-4F3A-8B85-BE63A8F6CE91Q36381304-95855599-C68A-4B18-87E3-2844897C9DF4Q37137516-D7FA1997-2747-4E8E-8621-9FB321C943FAQ37238650-211E951F-3EF6-486B-9E2F-B4E25B928A82Q38526526-409C3081-DA48-40CD-83A4-9737E85E6DE8Q38974584-DC2003F0-60C6-4EC4-BDDB-E7CB1EF8F644Q40399626-A4E937F9-065B-42F2-8780-DD07475F53FDQ40677595-54D35762-AD63-435C-BD2F-AC971C09B6D3Q40738827-26E81A70-5A71-45BB-8089-FEE02181C83BQ40740259-D544E4B4-5807-4E0C-B245-A293BBCBAC16Q40744457-A884815D-27DF-4616-A4B6-B7F0408E1B8BQ40806474-252BC0A7-8FD2-4C56-B031-B3C04014FA2EQ42578069-5F9DDB77-60AD-4FF8-B365-1EEA0840CF4CQ42810838-3E2A4645-F5C4-4F8E-B7CE-3456CC9D3418Q43976218-AA83DE02-0424-45D5-A10E-DEB30A29CDF3Q44800017-38862A4C-33AC-42F2-BA0F-224E1CBD0BF7Q45286157-43094F60-4714-4A18-8047-E436E15E547CQ53390497-33BD22C7-4598-4F97-83C2-3949B972F69AQ57450077-FC3F33F8-4902-44E4-801A-FC165E9F4371
P2860
JNK activation is required for JB6 cell transformation induced by tumor necrosis factor-alpha but not by 12-O-tetradecanoylphorbol-13-acetate.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
JNK activation is required for ...... tradecanoylphorbol-13-acetate.
@en
type
label
JNK activation is required for ...... tradecanoylphorbol-13-acetate.
@en
prefLabel
JNK activation is required for ...... tradecanoylphorbol-13-acetate.
@en
P2093
P2860
P356
P1476
JNK activation is required for ...... tradecanoylphorbol-13-acetate.
@en
P2093
P2860
P304
29672-29676
P356
10.1074/JBC.274.42.29672
P407
P577
1999-10-01T00:00:00Z